1. Home
  2. MNMD vs FISI Comparison

MNMD vs FISI Comparison

Compare MNMD & FISI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MNMD
  • FISI
  • Stock Information
  • Founded
  • MNMD 2019
  • FISI 1817
  • Country
  • MNMD United States
  • FISI United States
  • Employees
  • MNMD N/A
  • FISI N/A
  • Industry
  • MNMD Pharmaceuticals and Biotechnology
  • FISI Major Banks
  • Sector
  • MNMD Health Care
  • FISI Finance
  • Exchange
  • MNMD Nasdaq
  • FISI Nasdaq
  • Market Cap
  • MNMD 672.1M
  • FISI N/A
  • IPO Year
  • MNMD N/A
  • FISI 1999
  • Fundamental
  • Price
  • MNMD $8.65
  • FISI $28.45
  • Analyst Decision
  • MNMD Strong Buy
  • FISI Buy
  • Analyst Count
  • MNMD 10
  • FISI 4
  • Target Price
  • MNMD $28.11
  • FISI $29.75
  • AVG Volume (30 Days)
  • MNMD 2.2M
  • FISI 160.8K
  • Earning Date
  • MNMD 02-26-2025
  • FISI 01-30-2025
  • Dividend Yield
  • MNMD N/A
  • FISI 4.27%
  • EPS Growth
  • MNMD N/A
  • FISI N/A
  • EPS
  • MNMD N/A
  • FISI N/A
  • Revenue
  • MNMD N/A
  • FISI $110,758,000.00
  • Revenue This Year
  • MNMD N/A
  • FISI N/A
  • Revenue Next Year
  • MNMD N/A
  • FISI $7.80
  • P/E Ratio
  • MNMD N/A
  • FISI N/A
  • Revenue Growth
  • MNMD N/A
  • FISI N/A
  • 52 Week Low
  • MNMD $4.39
  • FISI $16.29
  • 52 Week High
  • MNMD $12.22
  • FISI $29.34
  • Technical
  • Relative Strength Index (RSI)
  • MNMD 59.89
  • FISI 60.77
  • Support Level
  • MNMD $7.86
  • FISI $27.22
  • Resistance Level
  • MNMD $10.20
  • FISI $28.45
  • Average True Range (ATR)
  • MNMD 0.80
  • FISI 0.73
  • MACD
  • MNMD 0.11
  • FISI 0.13
  • Stochastic Oscillator
  • MNMD 58.33
  • FISI 97.22

About MNMD Mind Medicine (MindMed) Inc.

Mind Medicine Inc is a biopharmaceutical company. The company produces to treat brain health disorders. The company discovers, develops, and deploys psychedelic inspired medicines and therapies to address addiction and mental illness. The company is assembling a compelling drug development pipeline of treatments based on psychedelic substances. The firm is having an approach towards developing the next generation of psychedelic-inspired medicines and therapies.

Share on Social Networks: